Myotonia congenita — A successful response to carbamazepine
- 91 Downloads
Myotonia congenita is a rare disease of skeletal muscle characterized by painless myotonia, generalized muscular hypertrophy and a non-progressive course. We report a 10-year-old girl with myotonia, “Herculean appearance” and electromyographic confirmation of myotonic discharges. There was a dramatic response to carbamazepine. The aim of this report is to make the readers aware of this entity which can be easily controlled with medication and also prevented by genetic counseling.
Key WordsMyotonia Myotonia congenita Carbamazepine
Unable to display preview. Download preview PDF.
- 1.Brett EM, Lake BD. Neuromuscular disorders: I Primary muscle disease and anterior horn cell disorders. In:Pediatric Neurology, 3rd edn. eds Brett EM. Churchill Livingstone, New York 1997:pp 70–77.Google Scholar
- 2.Victor M, Ropper AH: The Hereditary myotonias and periodic paralyses (The Channelopathies). InAdams and Victor’s Principles of Neurology, 7th edition. eds Victor M, Ropper AH. McGraw Hill (Medical publishing division) USA, 2001; pp 1553–1564.Google Scholar
- 3.Chew KTL, Wong YS, Teoh HL, Lim ECH. Myotonia congenita in a young active man-symptoms and physique tip the diagnosis.The Physician and Sports Medicine 2004: vol 32 (7): 26–29Google Scholar
- 4.Sarnat HB. Neuromuscular disorders. InNelson Textbook of Pediatrics, 17th edition. Eds Behrman RE, Kligeman RM, Jenson HB. Saunders, Philadelphia 2004; pp 2066.Google Scholar
- 7.Menkes JH. Diseases of the motor unit. InTextbook of Child Neurology.5th edition. eds Menkes JH. Williams and Winkins USA, 1995, pp 836–841Google Scholar
- 9.Moxley III RT, Tawil, Thornton CA. Channelopathies: Myotonic disorders and periodic paralysis. InPediatric Neurology. Principles and Practice. 3rd edition. Eds Swaiman KF, Ashwal S. Mosbs, Missouri. 1999. pp 1299–1310Google Scholar
- 14.Leyburn P, Walton JN. The treatment of myotonia: A controlled clinical trial.Brain 1959; 81–91.Google Scholar